Author:
Sen Zümrüt Duygu,Danyeli Lena Vera,Walter Martin
Publisher
Springer Berlin Heidelberg
Reference121 articles.
1. Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW (2017) Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 42:1210–1219
2. Adams JD, Castagnoli N, Trevor AJ (1978) Quantitative analysis of ketamine enantiomers. Proc West Pharmacol Soc 21:471–472
3. Ali F, Gerhard DM, Sweasy K, Pothula S, Pittenger C, Duman RS, Kwan AC (2020) Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines. Nat Commun 111(11):1–15
4. Ago Y, Tanabe W, Higuchi M, Tsukada S, Tanaka T, Yamaguchi T, Igarashi H, Yokoyama R, Seiriki K, Kasai A, Nakazawa T, Nakagawa S, Hashimoto K, Hashimoto H (2019) (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism. Int J Neuropsychopharmacol 22(10):665–674. https://doi.org/10.1093/ijnp/pyz041
5. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565–575